Merck Tbk. vs Semen Baturaja Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Semen Baturaja Tbk. trades at Rp154 (market cap 1.5T, 2.7M 24h volume). The key difference: Merck Tbk. and Semen Baturaja Tbk. are close in size by market cap, and Semen Baturaja Tbk. is more actively traded (2.7M versus 37.6K). Which is the better fit depends on your goals.
| MERK | SMBR | |
|---|---|---|
Market Cap | 1.7T | 1.5T |
Volume | 37.6K | 2.7M |
Lot | 376 | 26.98K |
Turnover | 144.47M | 412.89M |
Average Price | 3,842.23 | 153.01 |
Value | 144.47M | 412.89M |
Indicative Equilibrium Price | 3,840 | 154 |
Indicative Equilibrium Volume | 7 | 398 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Semen Baturaja (Persero) Tbk (the Company) was established by Deed of Notary Jony Frederik Berthold Tumbelaka Sinjai No. 34, in Jakarta, dated November 14, 1974, amended by the same notary on November 21, 1974, amended by the same notary on November 21, 1974 Deed No. 49.
Read more on SMBR →